Prof. Lim is the Executive Director, Department of Clinical Research and Advancement at Universiti Malaya, Kuala Lumpur, Malaysia. She is a Senior Consultant Endocrinologist and former Head of the Diabetes Care Unit, Universiti Malaya (2022-2025). She also holds honorary positions at the Chinese University of Hong Kong and the Baker Heart and Diabetes Institute, Melbourne, Australia. As a clinician-scientist, Prof. Lim’s major areas of interest are cardiometabolic medicine (epidemiology, molecular, and implementation science).  Prof. Lim sits on the Working Groups of the WHO Global Diabetes Compact, The Lancet Commission on Diabetes, and the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) Precision Medicine in Diabetes Initiative. She recognizes that every person with diabetes and non-communicable disease (NCD) is unique and warrants personalized care. To revolutionize health care, Prof. Lim aims to advance the implementation of Precision Medicine in Diabetes and NCD, taking into account differences in clinical presentation, genes, and lifestyles in Malaysian populations. These have led to several collaborations with the USA, UK, and other Asian countries. She has published in more than 130 high-impact journals, including The Lancet, Nature, Diabetes Care, and Science Bulletin.  Prof. Lim has received several awards, including the Universiti Malaya’s Top Cited Researcher 2024, World’s Top 2% Scientists by Stanford University for 4 consecutive years (2022-2025), and the European Foundation for the